Ingenovis Health Shows Rapid Growth in First Two Years

A leading healthcare workforce organization achieves unprecedented milestones as it celebrates its second anniversary. GREENWOOD VILLAGE, Colo.–(BUSINESS WIRE)–Ingenovis Health (Ingenovis), a leading healthcare talent provider, continues to climb the ladder of the industry’s top providers, tripling in size in two years and achieving more than $2 billion in annual revenue in 2022. Backed by private … [Read more…]

A New Study Suggests Energy4Life’s Bioenergetic Wearable Device May Have Positive Effects on Cellular Membrane

The study, led by Professor Hemal Patel, Vice-Chair of Medical Research at University of California at San Diego, observed positive unique and cell-specific effects on cellular membrane structure, mitochondrial function, oxidative stress, and viral infection protection PARK CITY, Utah–(BUSINESS WIRE)–A recent study by researchers at the University of California at San Diego, found that a … [Read more…]

Applied DNA Submits Validation Package to New York State Department of Health for Approval of Pharmacogenomic (PGx) Assay

– Expansion of Population-Scale Molecular Diagnostics Menu Positions ADCL Subsidiary for Long-Term Growth – STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #NYSDOH—Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (ADCL), has submitted a validation package to the New York … [Read more…]

Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone in the Treatment of Lennox-Gastaut Syndrome

RADNOR, Pa.–(BUSINESS WIRE)–$MRNS #MarinusPharma—Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to ganaxolone for the treatment of Lennox-Gastaut syndrome (LGS). This designation applies to the active moiety of … [Read more…]

AmbioPharm to Host a Sustainable Peptide Manufacturing Workshop at Biologics 2023

AmbioPharm aims for a holistic reduction of the carbon footprint by factoring in the complete manufacturing and supply chain impact in addition to greener chemistry initiatives. NORTH AUGUSTA, S.C.–(BUSINESS WIRE)–#cGMP—AmbioPharm, a worldwide leader in peptide API CDMO services, to host a workshop on sustainable peptide manufacturing at Biologics 2023 taking place in London, UK on … [Read more…]

Healthcare Veterans Louis Raya and Tyler Wells Join ADVault as Vice Presidents of Business Development

DALLAS–(BUSINESS WIRE)–ADVault, the nation’s leader in digital advance care planning, announced today the appointments of Louis Raya and Tyler Wells as Vice Presidents of Business Development. Both bring to their new positions deep experience in leveraging technology to effectively address the myriad of challenges currently being faced by healthcare providers nationwide. At ADVault, Raya’s primary … [Read more…]

Soleo Health Chief Executive Officer Drew Walk Named to NHIA Board of Directors

FRISCO, Texas–(BUSINESS WIRE)–#ComplexCare—Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the appointment of Chief Executive Officer Drew Walk to the National Home Infusion Association (NHIA) 2023-2024 Board of Directors. Walk joins a group of seasoned home infusion experts on the NHIA board, an industry governing body. NHIA is … [Read more…]

Sommetrics Presents Update on Pivotal SUPRA Sleep Apnea Trial at International Sleep and Breathing Conference

SAN DIEGO–(BUSINESS WIRE)–Sommetrics, a private company developing products and services to improve sleep health, today announced presentation of an interim update on its pivotal SUPRA study (Study Using Negative Pressure to Reduce Apnea) at the tri-annual, XVII International Symposium on Sleep and Breathing in Auckland, New Zealand. The presenter was Dr. Kingman Strohl, Program Director, … [Read more…]

InvoX Pharma’s F-star Announces Licence Agreement With Takeda for Second Novel Next-Generation Immuno-Oncology Bispecific Antibody

Bispecific antibody directed towards an undisclosed Takeda immuno-oncology target uses F-star’s proprietary Fcab™ and mAb2™ platforms LONDON–(BUSINESS WIRE)–InvoX Pharma Limited (“invoX”), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX 1177 HK) with an advancing pipeline of innovative products, today announces that F-star, an invoX company, has entered into a second licence agreement … [Read more…]

Ness Announces the First Premium Health and Wellness Credit Card with Partner sweetgreen and Other Top Brands

The Ness Credit Card—powered by Mastercard—rolls out rich benefits and a new way to reward living healthy in its public beta NEW YORK–(BUSINESS WIRE)–Ness, the next great credit card company putting health first, today announced the public beta launch of the Ness Card issued by The Bank of Missouri and powered by Mastercard. Now available … [Read more…]